Humalog
(insulin lispro)ApprovedSmall molecule
Insulin lispro is used to help people with diabetes control their blood sugar levels by replacing the insulin their body cannot make or use properly. It works quickly to lower blood sugar after meals.[2] Humalog is currently approved and in use across 7 indications[4].[1]
Humalog is one of 171 small molecule programs targeting Hypotension. It is currently in Approved.
7
Indications
122
Total Trials
3
Active Trials
170
Competitors
5
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
88 competitors in Cognition
#DrugCompanyPhaseTrials
1Azilect
TevaApproved
Vyvanse
TakedaApproved
Humalog
AAzienda U.S.L. 1 di Massa e Carrara
Approved
Ambien
PPurdue Pharma LP
Approved
Nimotop
AAzurity Pharmaceuticals
Approved
Namenda
AbbViePhase 3
Fintepla
UCBApproved
Epidiolex
Jazz PharmaceuticalsPhase 2
Nuplazid
AACADIA Pharmaceuticals Inc.
Phase 2
Remimazolam Tosilate
FFujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Type 1 Diabetes Mellitus23 trials
Show 20 more trials
Type 1 Diabetes21 trials
Show 18 more trials
Type 2 Diabetes14 trials
Show 11 more trials
ART13 trials
Show 10 more trials
Type 2 Diabetes Mellitus8 trials
Show 5 more trials
27 more indications
MPA7 trials
Type 2 Diabetic Patients2 trials
Gestational Diabetes2 trials
Safety and Efficacy2 trials
Hyperglycemia1 trial
Diabetes1 trial
PK/PD Study of Intranasal Insulin in Type I Diabetes
Unknown status·—·Phase 1·NCT01201278·20 enrolled
Hypertrophy1 trial
Type 1 Diabetic1 trial
Insulin Sensitivity1 trial
Absorption1 trial
Cognition1 trial
Tics1 trial
Chronic Kidney Disease1 trial
Randomized1 trial
Infusion1 trial
Asthma1 trial
Complication1 trial
Oxidative Stress1 trial
Dry Eye1 trial
Unspecified6 trials
Regulatory
FDA Approval Timeline[5]
Jun 14, 1996
INSULIN LISPRO
BLA BLA020563
Dec 22, 1999
HUMALOG MIX75/25
BLA BLA021017
Dec 22, 1999
HUMALOG MIX50/50 KWIKPEN
BLA BLA021018
May 26, 2015
HUMALOG KWIKPEN
BLA BLA205747
Dec 11, 2017
ADMELOG
BLA BLA209196
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Humalog drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for insulin lispro. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
Details